KEMPHARM INC. DL-0001
Healthcare · EUR · F
Price
€9.238
Cap
€200.47M
Earnings
—
30d Trend
+6.8%
55% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 58×Macro 0.99 (−1%)=57
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 60%
BRAIN47 HORIZON ANALYSIS
6-9 month momentum thesis — strong trend with confirmation
BRAIN47'S ASSESSMENT
I rate KEMPHARM INC. DL-0001 at 57/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 78/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
+10.6%
3 MONTHS
+22.6%
12 MONTHS
+31.5%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
6-9 month momentum thesis — strong trend with confirmation. Momentum (78) and Technical (57) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 55%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.